Racial and ethnic minorities are underrepresented in DRCRnet DME trials, despite experiencing more severe symptoms than other ...

This article will explain why eye screenings are crucial, how diabetic retinopathy develops, and what you can do to protect your vision.

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal ...

Rwanda is set to become home to Africa’s first manufacturing plant for eye care products and monoclonal antibodies targeting cancer, with completion expected by 2026, according to Dr. Menghis Bairu, ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME) ANI plans to begin marketing ...

New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients with more treatment options, optimizing timing, and introducing innovative ...

including diabetic macular edema. ) injection treatment approach offers unprecedented access to the back of the eye, where sight-threatening disease often occurs. The Company’s unique platform ...

The Food and Drug Administration (FDA) has approved Iluvien® (fluocinolone acetonide intravitreal implant) for the treatment of chronic non-infectious ...

Valeda uses yellow, red, and near-infrared light to stimulate cells in the eye. More studies are needed to measure the full effect and safety of red light as an eye therapy for all types of ...

In the trial, people with diabetic macular edema who received Susvimo refilled ... 5-mg ranibizumab intravitreal injections (9.6 and 9.4 eye chart letters, respectively). The most common ocular ...